IN THE midst of the fight to control Zika, the top public health agency in the United States has been engaged in an intense internal debate about the best way to test whether someone has been infected with the mosquito-borne virus.
At the center of the debate at the Centers for Disease Control and Prevention is one of the leading experts on Zika virus. Robert Lanciotti is chief of the CDC lab responsible for developing tests to diagnose viral diseases such as Zika that are transmitted by mosquitoes, ticks and fleas.
Lanciotti was demoted in May after he raised concerns inside and outside the agency about the CDC's decision in the spring to recommend a new test for Zika. That test is substantially less effective than another established test, he said, and misses nearly 40 percent of Zika infections. He also said the agency withheld information about testing differences from state and local public health laboratories.
The scientist was reinstated to chief of his lab in July after he filed a whistleblower retaliation claim, according to documents made public Tuesday by the Office of Special Counsel, an independent federal watchdog agency that handles whistleblower complaints.
The CDC did not immediately comment Tuesday.
The questions raised by Lanciotti prompted an internal investigation by the CDC. Its report was among the documents released Tuesday, when a review of the investigation was sent to the White House and Congress.
CDC investigators acknowledged in their report that testing for Zika is difficult and needs to be improved. The agency said it made improvements that will boost the new test's sensitivity, according to the CDC's investigative report. The internal investigation also found that the CDC acted reasonably when it withheld the conflicting test data from state public health labs. Doing so could have created "considerable confusion during an ongoing emergency response," the investigators said.
The issues raised in the debate illustrate the challenges of managing one of the world's biggest public health crises without emergency funding. In particular, it shows the pressure the CDC was under to quickly develop an accurate diagnostic test for a disease that is still poorly understood.
Many state and local labs have a backlog of samples to be tested for Zika. The problem is particularly urgent for pregnant women because Zika can cause severe defects in developing fetuses. The tests in question are the first of three types of tests for Zika exposure.
During a 2007 Zika outbreak in Micronesia, Lanciotti's lab developed a test to detect traces of the Zika virus in a person's blood. Called the Singleplex, it detects genetic material up to seven days after onset of illness.
When the Zika outbreak hit Brazil, this test, and another one also developed by Lanciotti's lab to detect antibodies the body makes to fight infections, were used on samples submitted to the CDC for diagnosis.
Determining whether someone has been infected with Zika is enormously difficult because most infected people don't have symptoms. And many countries in South and Central America and the Caribbean hard hit by Zika have also had outbreaks of two related viruses - dengue and chikungunya - that officials worried could be confused with Zika.
Last fall, scientists at CDC's dengue branch lab in Puerto Rico began work on a diagnostic tool that would detect all three viruses in one test. Lanciotti warned that combining the three might reduce their individual sensitivities. The original goal was to develop a test and conduct extensive evaluation necessary for approval by the Food and Drug Administration to market the test.
But by the end of last year, the worsening Zika outbreak "increased the urgency to quickly develop an assay," CDC investigators found. The virus was spreading quickly, and there was increasing evidence linking the virus to severe birth defects. In March, the CDC sought emergency FDA approval to allow the new test to be distributed to state and local public health labs. One day later, on March 17, the FDA approved emergency use of the test, called Trioplex. Shortly thereafter, the CDC notified public health labs about the test and began shipping it.
Lanciotti compared the two tests and found that the Trioplex missed 39 percent of Zika infections that were detected by the Singleplex. An independent laboratory came to a similar conclusion. But a study by the CDC lab in Puerto Rico found no difference in sensitivity. CDC investigators said they were unable to reach a "statistically-valid conclusion about the relative performance" of the two tests.
Within the agency, "there was extensive communication, debate, analysis and discussion" about the performance of the two tests, according to the CDC investigators. CDC officials decided the difference between the two tests was not conclusive.
Lanciotti disagreed with the decision and in mid-April, he emailed his contacts at about 30 public health laboratories. He notified them that his own lab at Fort Collins was continuing to use the Singleplex instead of the Trioplex because of its greater relative sensitivity "that we have just established/became aware of through comparative analyses in several laboratories."
The email caused confusion among state labs and apparently angered some other CDC officials who did not know that Lanciotti had sent the email. One official told Lanciotti his email "created more trouble and confusion than it clarified."
The CDC notified the state labs about which tests were recommended in the Zika response but did not address the differences in performance directly. The agency said the low level of Zika virus in the blood could "pose a challenge" for molecular testing and said it was continuing to evaluate the performance of its tests.
Lanciotti remained "deeply concerned with what he viewed as CDC's promotion of an inferior" test, according to CDC investigators. In mid-May, he emailed senior CDC leaders and asked again that the test's lesser sensitivity be shared with public health laboratories, accusing the CDC of deliberately withholding information.
A week later, he was reassigned to a nonsupervisory position.
In late August, the CDC made several changes to improve the test's sensitivity, such as authorizing laboratories to use larger volumes of blood that would contain more virus and make the evidence easier to detect.
In his response to the CDC investigation of his complaint, Lanciotti acknowledged that the agency's improvements to the new test may increase its sensitivity. But, he noted, that action happened four months after he first raised the issues.
In the report released Tuesday, special counsel Carolyn Lerner noted that Lanciotti "raises serious concerns about each of the CDC's findings," including the methodology the agency used to discount findings that the new Trioplex test "may detect fewer Zika infections" than the established test.
She urged the CDC to respond to his concerns and use his expertise as the agency "works to ensure it is implementing the most effective testing methods" in its Zika response. She added: "I also encourage the CDC to promote scientific debate within its labs. Whistleblowers should be encouraged to speak out on matters of public concern."
The Washington Post
Thu Sep 29 2016
The issues raised in the debate show the pressure the CDC was under to quickly develop an accurate diagnostic test for a disease that is still poorly understood. - Filepic from Freeimages
Who is Prabowo Subianto, incoming president of Indonesia?
A wealthy ex-general with ties to Indonesia's popular outgoing president and its dictatorial past, looks set to be its next leader.
Iran's supreme leader says Hamas leader's death will not halt 'Axis of Resistance'
The "Axis of Resistance", built up with years of Iranian support, includes Hamas, the Lebanese Hezbollah group, the Houthi movement in Yemen, and various Shi'ite groups in Iraq and Syria.
Putin says Russia willing to seek compromises between Iran and Israel
Russia is ready to help seek compromises between arch-foes Israel and Iran, President Vladimir Putin said on Friday, saying these would be difficult but possible.
What proposals will Russia push at the BRICS summit?
The proposal is also to establish a BRICS reinsurance company to allow uninterrupted shipment of goods and key commodities between members.
Indonesia's free meals plan in the spotlight as Prabowo readies for office
Prabowo calls the programme one of the main drivers of economic growth, eventually set to add an estimated 2.5 million jobs.
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.
Israeli strikes kill 33 people in Jabalia refugee camp in Gaza, medics say
Residents of Jabalia said Israeli tanks had reached the heart of the camp after pushing through suburbs and residential districts.
Liam Payne's ex-partner calls for media restraint after 'painful' death
Cheryl Tweedy used her statement to urge the media to remember they had a seven-year-old son, Bear, who could read the reports.
Analysts: Indonesia's strong MoF leadership team to boost investor confidence
Sri Mulyani Indrawati as head of Indonesia's Ministry of Finance is expected to instil confidence among investors.
Biden offers both a carrot and a stick to Israel as his term nears an end
Israel has frequently resisted US advice and has caused political difficulties for the Biden administration.
Putin says BRICS will generate most of global economic growth
Russian President Vladimir Putin will host a summit of the group in the city of Kazan on Oct. 22-24.
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.